Texas Permanent School Fund’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-18,329
Closed -$275K 1521
2016
Q2
$275K Sell
18,329
-839
-4% -$10.8K ﹤0.01% 1428
2016
Q1
$233K Sell
19,168
-662
-3% -$9.28K ﹤0.01% 1451
2015
Q4
$315K Buy
19,830
+103
+0.5% +$1.62K ﹤0.01% 1408
2015
Q3
$302K Buy
19,727
+345
+2% +$7.46K ﹤0.01% 1417
2015
Q2
$471K Sell
19,382
-1,024
-5% -$24.5K 0.01% 1367
2015
Q1
$474K Buy
20,406
+10
+0% +$265 0.01% 1378
2014
Q4
$512K Sell
20,396
-141
-0.7% -$4.14K 0.01% 1368
2014
Q3
$639K Sell
20,537
-1,189
-5% -$32.2K 0.01% 1284
2014
Q2
$562K Buy
+21,726
New +$483K 0.01% 1380

Texas Permanent School Fund's SGNT Position: Q3 2016 in Review

Texas Permanent School Fund sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 18,329 shares — an estimated $275K sold.

Texas Permanent School Fund first reported a position in SGNT in Q2 2014 and held it in 9 quarters. The position peaked at $639K in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Texas Permanent School Fund reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Texas Permanent School Fund sold 18,329 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $275K.
  • Texas Permanent School Fund first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 9 quarters.
  • Texas Permanent School Fund's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $639K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Texas Permanent School Fund's 13F filing for Q3 2016, filed 27 Oct 2016.